Which diseases are related to the gut microbiota?

The human gut microbiota is a dynamic community that influences digestion, immunity, metabolism, and neural signaling. Growing evidence links shifts in microbial composition—dysbiosis—to a wide range of conditions. This article summarizes major diseases associated with gut microbiota changes and explains how microbial profiling can inform clinical understanding and personalized care.

Key conditions associated with gut microbiota

Microbial imbalance is implicated in both gastrointestinal and systemic diseases. Notable associations include:

• Irritable Bowel Syndrome (IBS): Altered bacterial populations and gas-producing organisms are common findings in IBS cohorts, and specific microbial signatures can relate to constipation- or diarrhea-predominant symptoms.
• Inflammatory Bowel Disease (IBD): Patients with Crohn’s disease and ulcerative colitis frequently show reduced diversity and increased pro-inflammatory taxa that may perpetuate mucosal inflammation.
• Metabolic disorders: Obesity and type 2 diabetes correlate with compositional shifts that affect energy harvest, bile acid metabolism, and low-grade systemic inflammation.
• Cardiovascular risk: Certain gut microbes metabolize dietary nutrients into trimethylamine, a precursor of TMAO, which has been associated with atherosclerotic risk in epidemiologic studies.
• Neuropsychiatric conditions: The gut–brain axis links microbial metabolites and immune mediators to mood and cognition; altered microbiota has been reported in depression and anxiety.
• Autoimmune and inflammatory diseases: Dysbiosis and increased intestinal permeability have been observed in rheumatoid arthritis, multiple sclerosis, and other autoimmune disorders.
• Allergies and intolerances: Early-life microbial exposures shape immune tolerance; disruptions can increase vulnerability to atopic disease and food sensitivities.

Intestinal disorders and dysbiosis

Specific intestinal conditions such as small intestinal bacterial overgrowth (SIBO), diverticulitis, celiac disease, and various forms of colitis show clear microbial contributions. For example, SIBO involves excessive bacterial loads in the small intestine that interfere with nutrient absorption and motility. Understanding these microbial patterns can guide dietary, antimicrobial, or probiotic strategies.

Drivers of dysbiosis

Common factors that alter the gut ecosystem include antibiotic exposure, low-fiber or high-processed-food diets, chronic stress, disrupted sleep, infections, and environmental toxins. These influences can reduce beneficial taxa, promote opportunistic organisms, and alter metabolite production (e.g., short-chain fatty acids) that normally support gut barrier and immune function.

Role of microbiome testing

Microbiome profiling can identify compositional imbalances, functional potential, and metabolite-related risks. For clinicians and researchers, these data inform hypotheses about disease mechanisms and enable targeted interventions. For a general overview of diseases tied to gut microbes, see this detailed article on which diseases are related to the gut microbiota: which diseases are related to the gut microbiota.

Further practical guidance on preparing for and interpreting tests can be found in resources such as the insurance and coverage considerations and common pitfalls to avoid: top microbiome test mistakes. A concise checklist of common errors is also available externally: Top 10 Mistakes to Avoid When Taking a Gut Microbiome Test.

Clinical interpretation should integrate microbiome data with symptoms, labs, and medical history. Some platforms provide functional readouts and recommendations; examples of such testing options include third-party services like microbiome test.

Conclusion

Many common diseases show associations with gut microbiota composition and function. While causality is complex and often bidirectional, microbiome-informed assessment is a valuable component of a broader, evidence-based health evaluation.